• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2012 HAYES, Inc. Oasis wound matrix (Cook Biotech Inc.) for lower extremity ulcers
2012 Agency for Healthcare Research and Quality (AHRQ) Long-term care for older adults: a review of home and community-based services versus institutional care
2012 Agency for Healthcare Research and Quality (AHRQ) Biologic and nonbiologic systemic agents and phototherapy for treatment of chronic plaque psoriasis
2012 Agency for Healthcare Research and Quality (AHRQ) Biomarkers for assessing and managing iron deficiency anemia in late-stage chronic kidney disease
2012 Agency for Healthcare Research and Quality (AHRQ) Acute migraine treatment in emergency settings
2012 Agency for Healthcare Research and Quality (AHRQ) Local hepatic therapies for metastases to the liver from unresectable colorectal cancer
2012 Agency for Healthcare Research and Quality (AHRQ) Evaluation and treatment of cryptorchidism
2012 Agency for Healthcare Research and Quality (AHRQ) Interventions to improve patient adherence to hepatitis C treatment: comparative effectiveness
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Day surgery: a systematic overview]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Trametinib for advanced or metastatic BRAF V600E mutation-positive melanoma
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Avastin® for age-related macular degeneration]
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) IFEDH - Innovative Framework for Evidence Based Decision Making in Health Care: Standards on how to parameterise models via published literature: Input of the LBI-HTA (WP 4.2)
2012 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Hyperthermia in breast-, bladder-, cervix carcinoma and soft tissue sarcoma patients
2012 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Efficacy and safety of ornithine in treating hyperammonemia from acute and chronic liver diseases]
2012 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Efficacy and safety of the artificial urinary sphincter (AS) in treating postprostatectomy urinary incontinence]
2012 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Efficacy and safety of tocilizumab in treating rheumatoid arthritis]
2012 Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS ) [Uterine artery embolization in patients aiming to preserve the uterus]
2012 HAYES, Inc. Orthotic compression bracing for treatment of pectus carinatum
2012 HAYES, Inc. Percutaneous epidural adhesiolysis for chronic back pain
2012 HAYES, Inc. Percutaneous needle aponeurotomy for Dupuytren contracture
2012 HAYES, Inc. Pipeline embolization device (Covidien ev3) for treatment of intracranial aneurysms
2012 HAYES, Inc. Plasmapheresis for hypertriglyceridemia-induced pancreatitis
2012 HAYES, Inc. Provent sleep apnea therapy (Ventus Medical Inc.)
2012 HAYES, Inc. P-Stim (Biegler GmbH) auricular electroacupuncture for pain management
2012 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [1st Expert Panel on viper venomous bite in Spain]
2012 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Economic evaluation of the introduction of the HPV vaccine in Spain to prevent cervical cancer]
2012 HAYES, Inc. Pulmonary thromboendarterectomy for treatment of pulmonary hypertension
2012 HAYES, Inc. Qsymia (phentermine/topiramate; Vivus Inc.) for obesity management
2012 HAYES, Inc. Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in adults
2012 HAYES, Inc. Relieva balloon sinuplasty (Acclarent Inc.) for chronic sinusitis in children
2012 HAYES, Inc. Sacroiliac joint fusion for the treatment of adult low back pain
2012 HAYES, Inc. Selenia dimensions digital tomosynthesis system (Hologic Inc.) for diagnostic mammography
2012 HAYES, Inc. Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after general abdominal surgery
2012 HAYES, Inc. Seprafilm adhesion barrier (Genzyme Corp.) for prevention of abdominal adhesions after gynecologic surgery
2012 HAYES, Inc. SNaP wound care system (Spiracur Inc.) for treatment of lower extremity ulcers
2012 HAYES, Inc. Solesta (Q-Med AB) for treatment of fecal incontinence
2012 HAYES, Inc. Somatosensory evoked potentials (SEPs) for intraoperative monitoring during spinal cord surgery for trauma or tumors
2012 HAYES, Inc. Sphincter pharyngoplasty for velopharyngeal insufficiency in children
2012 HAYES, Inc. Subcutaneous implantation of estradiol pellets for postmenopausal disorders
2012 HAYES, Inc. Transarterial hepatic yttrium-90 radioembolization for treatment of unresectable intrahepatic cholangiocarcinoma
2012 HAYES, Inc. VersaJet II hydrosurgery system (Smith & Nephew Inc.) for treatment of burns
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) Evaluation of acellular dermal matrix for breast reconstruction: an update
2012 HAYES, Inc. X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2012 HAYES, Inc. Breast cancer susceptibility 1 and 2 (BRCA1/2) gene testing for hereditary breast and ovarian cancer (HBOC)
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) The hybrid operating room. Should one be available for cardiovascular-thoracic procedures in the MUHC? A brief report
2012 Technology Assessment Unit of the McGill University Health Centre (MUHC) Single-dose intraoperative radiotherapy using Intrabeam® for early-stage breast cancer: a health technology assessment
2012 HAYES, Inc. C-abl oncogene 1, nonreceptor tyrosine kinase (ABL1) variant testing in acquired tyrosine kinase inhibitor (TKI) resistance
2012 HAYES, Inc. CancerTYPE ID® (bioTheranostics Inc.) for cancer of unknown primary (CUP)
2012 HAYES, Inc. Corus® CAD
2012 HAYES, Inc. Cytochrome P450 (CYP450) genotyping to predict response to antidepressant and antipsychotic medications
2012 HAYES, Inc. Ki-67 (MKI67) proliferation marker testing in ductal carcinoma in situ (DCIS) and breast cancer
2012 HAYES, Inc. Oncotype DX for the prediction of recurrence of invasive breast cancer
2012 HAYES, Inc. Panexia test for hereditary pancreatic cancer
2012 HAYES, Inc. PreDx® diabetes risk score (DRS)
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Eplerenone (Inspra) 25mg and 50mg film-coated tablets
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sildenafil (Revatio) 10mg/ml powder for oral suspension
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Bortezomib (Velcade®) 3.5 mg subcutaneous injection
2012 All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Argatroban (Exembol®) 100 mg/ml concentrate for solution for infusion
2012 The Swedish Council on Health Technology Assessment (SBU) [Implementation of psychiatric guidelines and evidence-based knowledge in the primary care sector]
2012 The Swedish Council on Health Technology Assessment (SBU) [Methods to estimate and measure renal function (glomerular filtration rate)]
2012 Andalusian Health Technology Assessment Area (AETSA) [Allomap genetic test for cardiac transplant rejection]
2012 Andalusian Health Technology Assessment Area (AETSA) [Heterochromatic flicker photometry for the detection of the risk of age-related macular degeneration]
2012 Andalusian Health Technology Assessment Area (AETSA) [MicroRNAs as a diagnostic tool for lung cancer]
2012 Andalusian Health Technology Assessment Area (AETSA) [Invasive telemonitoring in patients with heart failure]
2012 Andalusian Health Technology Assessment Area (AETSA) [Digital tomosynthesis of the breast]
2012 Andalusian Health Technology Assessment Area (AETSA) [Magnetic resonance guided focused ultrasound for uterine myomas ablation]
2012 Andalusian Health Technology Assessment Area (AETSA) [High-dose chemotherapy in the salvage treatment of metastatic germ cell tumours]
2012 Andalusian Health Technology Assessment Area (AETSA) [Radiosurgery and stereotactic body radiation therapy. Efficacy, safety and efficiency in primary lung cancer and pulmonary oligometastases]
2012 Medical Advisory Secretariat (MAS) Specialized community-based care: an evidence-based analysis
2012 Agency for Healthcare Research and Quality (AHRQ) Skin substitutes for treating chronic wounds
2012 Agency for Healthcare Research and Quality (AHRQ) Management of asymptomatic carotid stenosis
2012 Penn Medicine Center for Evidence-based Practice (CEP) Post-discharge telephone calls to reduce hospital readmissions
2012 Penn Medicine Center for Evidence-based Practice (CEP) Systematic reviews of robot-assisted surgery: update
2012 Penn Medicine Center for Evidence-based Practice (CEP) Supplementary feedings for healthy breastfed full-term infants
2012 Penn Medicine Center for Evidence-based Practice (CEP) Composite indexes of provider performance
2012 Penn Medicine Center for Evidence-based Practice (CEP) Biliary drainage for chemotherapy patients
2012 Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for use of screening and preventive services
2012 Penn Medicine Center for Evidence-based Practice (CEP) Reconciliation of data from differing electronic medical records
2012 Penn Medicine Center for Evidence-based Practice (CEP) Comparative effectiveness of troponin tests for diagnosis of myocardial infarction
2012 Blue Cross Blue Shield Association (BCBS) Special report: chronic noncancer pain—long-term opioid benefits and harms
2012 Blue Cross Blue Shield Association (BCBS) Bariatric surgery in patients with diabetes and body mass index less than 35 kg/m2
2012 Blue Cross Blue Shield Association (BCBS) Laparoscopic adjustable gastric banding in patients with body mass index less than 35 kg/m2 with weight-related comorbidity
2012 Blue Cross Blue Shield Association (BCBS) Wireless motility capsule in the diagnosis and evaluation of gastroparesis or slow-transit constipation
2012 Blue Cross Blue Shield Association (BCBS) Beta amyloid imaging with Positron Emission Tomography (PET) for evaluation of suspected alzheimer's disease or other causes of cognitive decline
2012 Blue Cross Blue Shield Association (BCBS) Accelerated radiotherapy after breast-conserving surgery for early stage breast cancer
2012 Blue Cross Blue Shield Association (BCBS) Special report: treatments for castration-resistant metastatic prostate cancer
2012 Blue Cross Blue Shield Association (BCBS) Multianalyte testing for the evaluation of adnexal masses
2012 Blue Cross Blue Shield Association (BCBS) Balloon sinus ostial dilation for treatment of chronic rhinosinusitis
2012 Blue Cross Blue Shield Association (BCBS) Sequencing-based tests to determine fetal down syndrome (trisomy 21) from maternal plasma DNA
2012 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of human papillomavirus (HPV) testing, followed by liquid-based cytology triage of positive results, in primary screening for cervical cancer?
2012 Scottish Health Technologies Group (SHTG) High-risk human papillomavirus (HPV) testing as triage for women with mild or borderline cytology abnormalities
2012 Scottish Health Technologies Group (SHTG) Is radiofrequency ablation (RFA) treatment a suitable clinically and cost-effective treatment to be offered to patients with hepatocellular cancer in NHSScotland?
2012 Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of microprocessor-controlled artificial knees compared with non-microprocessor-controlled alternatives?
2012 Scottish Health Technologies Group (SHTG) Radiofrequency ablation for Barrett's oesophagus with high grade dysplasia
2012 Scottish Health Technologies Group (SHTG) The use of functional electrical stimulation (FES) in adults with dropped foot. This evidence note updates evidence note 25 published in October 2008
2012 Scottish Health Technologies Group (SHTG) Safety and risk associated with free standing midwife led maternity units. This evidence note updates evidence note 18 published in August 2007
2012 Scottish Health Technologies Group (SHTG) What implications does the organisation of vascular services have for rates of amputation?
2012 Scottish Health Technologies Group (SHTG) What is the published evidence of an association between hospital volume and outcome in elective carotid endarterectomy surgery?
2012 Scottish Health Technologies Group (SHTG) Is there a difference in operative mortality between endovascular aneurysm repair and open surgery in elective abdominal aortic aneurysm?
2012 Scottish Health Technologies Group (SHTG) What is the published evidence of an association between hospital volume and operative mortality for surgical repair (open and endovascular) of unruptured and ruptured abdominal aortic aneurysms?